- Presents standard scientific and cutting-edge technologies to diagnose and stage NAFLD and to confirm its extrahepatic manifestations
- Provides details on the pathophysiological mechanisms in NAFLD and NASH
- Presents the current randomized controlled trials which measure the effectiveness of new promising therapeutic agents and intervention diets for NALFD
The book is a compact yet comprehensive practical resource that highlights all must-know information on non-alcoholic fatty liver disease (NAFLD).
Covering the major issues dominating the field, this book offers a broad vision on NAFLD using key data for a deep and thorough understanding of the latest diagnostic methods, treatment options, potential complications, and disease management strategies to improve patient outcomes.
The volume bridges the trans-disciplinary divide between hepatologists, cardiologists, nephrologists, psychiatrists, oncologists and dermatologists in order to cover the complex management of NAFLD in a single volume.
It operates under a modern definition of NAFLD that acknowledges the range of presentations related to extrahepatic complications that hepatologists see in daily practice, while also delving into unanswered questions and future directions regarding treatment options.
Offering practical, clinical guidance in addition to capturing the new promising therapeutic approaches in the pipeline, this book is an essential reference for clinicians, researchers and students.
Table of Contents- The Nomenclature and Definition of Nonalcoholic Fatty Liver Disease
- Nonalcoholic Fatty Liver Disease Versus Metabolic Associated Fatty Liver Disease
- Natural History of Nonalcoholic Fatty Liver Disease
- Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
- Genetics and Epigenetics in Nonalcoholic Fatty Liver Disease
- The Place of Transabdominal Liver Biopsy in Nonalcoholic Fatty Liver Disease
- Alternative Methods for Liver Biopsy: Endoscopic Ultrasound-Guided and Transjugular Liver Biopsy
- Morphopathology of Nonalcoholic Fatty Liver Disease
- 2D Shear Wave Elastography Performance in the Diagnosis of Nonalcoholic Fatty Liver Disease
- Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter for Staging Nonalcoholic Fatty Liver Disease
- The Value of Serologic Markers/Scores in the Assessment of Nonalcoholic Fatty Liver Disease
- Nonalcoholic Fatty Liver Disease Within Other Causes of Chronic Liver Diseases
- Pathophysiology and Risk Stratification in Cardiovascular Diseases and NAFLD
- Type 2 Diabetes Mellitus and Insulin Resistance in Nonalcoholic Fatty Liver Disease
- Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease
- Endocrinopathies in Nonalcoholic Fatty Liver Disease
- Nonalcoholic Fatty Liver Disease and Extrahepatic Malignancies
- Psychological Burden of NAFLD and Psychiatric Disorders as Extrahepatic Manifestations
- Obstructive Sleep Apnea Syndrome and Nonalcoholic Fatty Liver Disease
- Nonalcoholic Fatty Liver Disease and Psoriasis
- Current Management and Pipeline Treatment Approaches in NAFLD: Summary of Ongoing RCTs and Future Directions
- Practical Clinical Cases in Nonalcoholic Fatty Liver Disease
